Oct 23, 2025 07:30AM
Oct 23, 2025 07:30AM
Jun 12, 2025 04:02PM
Jun 12, 2025 04:01PM
Mar 7, 2025 06:46AM
Feb 27, 2025 07:30AM
Dec 9, 2024 07:32AM Silence Therapeutics (SLN) Presents Promising Phase 1 Data in Polycythemia Vera Patients at the American Society of Hematology (ASH) Annual Meeting
Dec 9, 2024 07:30AM
Jun 27, 2024 07:30AM
Jun 27, 2024 07:30AM
Jun 21, 2024 06:34AM
Jan 17, 2024 08:00AM
Nov 17, 2023 07:02AM
Nov 17, 2023 07:00AM  Virpax Pharmaceuticals Announces Leadership Transition
May 25, 2023 01:30AM
May 12, 2023 04:08PM
Apr 4, 2023 07:02AM
Apr 4, 2023 07:00AM
Mar 28, 2023 08:58AM
Nov 10, 2022 07:00AM
Sep 29, 2022 07:00AM Silence Therapeutics Announces Preliminary Single Dose Results from SLN124 Phase 1 Study in Patients with Thalassemia
Sep 15, 2022 09:15AM
Sep 8, 2022 07:00AM
May 16, 2022 07:00AM
Mar 17, 2022 07:00AM
Dec 7, 2021 05:00AM
Oct 21, 2021 08:35AM
Oct 21, 2021 08:30AM Silence Therapeutics Provides mRNAi GOLD™ Platform and Pipeline Updates at 2021 R&D Day
Mar 30, 2021 07:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All